CME/CE Accredited Session
Non-CME/CE Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
Differences in the African American Diet and Strategies to Impact Choices: Patient-Centered Clinical Care of African Americans
Gregory L. Hall, MD
You may be aware of dietary differences in the African American community, but you may not know the full story. Historical, cultural, and socioeconomic factors play a significant role in the food choices African Americans often make. Before you tell your next African American patient to “eat better,” you need to watch this presentation to understand the research-based differences in the African American diet and how it has evolved. You will also see the evidence behind the harmful effects of the staple African American diet and, most importantly, walk away with strategies you can use tomorrow to effect change in this patient population.
Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, Director, Center for African American Health, Research, Education & Policy, Cleveland, OH
Hospitalization: An Opportunity to Optimize Care for Patients with Heart Failure
A brief review on how hospitalizations impact heart failure trajectory and how guideline-directed care can improve outcomes for patients with heart failure. Dr. Jennifer Brown presents compelling information on why hemodynamic status and biomarkers (such as BNP and NT-proBNP) are important prognostic indicators in patients hospitalized due to heart failure.
For more HF and cardiovascular disease education content, please see www.HallsofScience.com
Sponsored by Novartis Pharmaceuticals Corporation
Heart Failure with Preserved Ejection Fraction (HFpEF): An Overview
An overview of the patient demographics and comorbidities that drive the pathophysiology of disease and precipitate hospitalization for patients with HFpEF. Clinical guidelines are discussed, focusing on addressing risk factors and comorbid conditions, as well as phenotyping, which may assist in the management of patients with HFpEF.
For more HF and cardiovascular disease education content, please see www.HallsofScience.com
Sponsored by Novartis Pharmaceuticals Corporation